• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Hosp Infect . Incidence and Characteristics of Nosocomial Influenza in a Country With Low Vaccine Coverage

tetano

Editor, Senior Moderator
J Hosp Infect


. 2020 Jun 12;S0195-6701(20)30290-5.
doi: 10.1016/j.jhin.2020.06.005. Online ahead of print.
Incidence and Characteristics of Nosocomial Influenza in a Country With Low Vaccine Coverage


D L Paz[SUP] 1 [/SUP], C Pronier[SUP] 2 [/SUP], B Bayeh[SUP] 3 [/SUP], S Jouneau[SUP] 4 [/SUP], C Grolhier[SUP] 2 [/SUP], A Le Bot[SUP] 1 [/SUP], F B?n?zit[SUP] 1 [/SUP], V Thibault[SUP] 2 [/SUP], P Tattevin[SUP] 5 [/SUP]



Affiliations

Abstract

Background: Influenza vaccination coverage is low in France, in at-risk patients and in healthcare workers.
Aim: We aimed to estimate the incidence of nosocomial influenza, its characteristics and outcome.
Methods: During one influenza season, we retrospectively evaluated all cases of documented influenza. Inpatients with symptoms onset ≥48 h after admission were enrolled. Data were collected on a standardized questionnaire.
Results: From November 2017 to April 2018, 860 patients tested positive for influenza by polymerase chain reaction analysis on a respiratory sample. Among them, 204 (23.7%) were diagnosed ≥48 h after admission, of whom 57 (6.6% of all influenza cases) fulfilled inclusion criteria for nosocomial influenza: 26 women and 31 men, median age 82 years (interquartile range, 72.2-86.9). Twenty patients (38.6%) had recently (<6 months) received the seasonal influenza vaccine. Median time between admission and symptoms onset, and between symptoms onset and diagnosis were, respectively, 11 days (7-19.5) and 29 h (15.5-48). Influenza was mostly acquired in a double-bedded room (N = 39, 68.4%), with documented exposure in 14 cases. Influenza B virus was more common in nosocomial (46/57, 80.7%), than in community-acquired cases (359/803, 44.6%), P<0.001. Mortality rate at three months was 15.8% (N = 9). Incidence of nosocomial influenza was estimated at 0.22 per 1000 hospital-days during the study period.
Conclusion: Nosocomial influenza is not rare in elderly inpatients, and may have severe consequences. Influenza B virus was over-represented, which suggests higher transmissibility and/or transmission clusters.

Keywords: Elderly; Incidence; Influenza B virus; Nosocomial influenza; Outcome; Vaccine.
 
Back
Top Bottom